Vidacare Corporation Release: Study Finds Intraosseous Infusion is Equivalent to Intravenous Infusion During Therapeutic Hypothermia
1/17/2012 9:55:35 AM
SAN ANTONIO--(BUSINESS WIRE)--The results of a study conducted by Vidacare Corporation comparing whether Intraosseous (IO) vascular access may be used to infuse chilled saline as effectively as peripheral intravenous (IV) access to achieve therapeutic hypothermia found no statistical difference between the two routes. The findings were announced on January 12 at an oral presentation at the National Association of EMS Physicians® 2012 Annual Meeting by Dr. Larry J. Miller and the Science and Clinical team from Vidacare Corporation, makers of the EZ-IO® Intraosseous Infusion System.
comments powered by